anti-Biliverdin Reductase A (BLVRA) Antibodies

The protein encoded by BLVRA belongs to the biliverdin reductase family, members of which catalyze the conversion of biliverdin to bilirubin in the presence of NADPH or NADH. Additionally we are shipping Biliverdin Reductase Proteins (15) and Biliverdin Reductase Kits (10) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
BLVRA 644 P53004
BLVRA 109778 Q9CY64
BLVRA 116599 P46844
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-Biliverdin Reductase Antibodies at antibodies-online.com

Showing 10 out of 157 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Delivery Price Details
Rat Rabbit Un-conjugated ICC, IHC, WB Figure. Western Blot; Sample: Lane1: Rat Serum; Lane2: Rat Brain Tissue; Lane3: Rat Liver Tissue; Lane4: Rat Lung Tissue; Lane5: Rat Kidney Tissue. Figure. Western Blot; Sample: Recombinant BLVRA, Rat. 100 μL 13 to 16 Days
$266.00
Details
Human Rabbit FITC ICC, IF, IP, IHC, WB Immunocytochemistry/Immunofluorescence analysis using Rabbit Anti-BVR Polyclonal Antibody . Tissue: HeLa Cells. Species: Human. Fixation: 2% Formaldehyde for 20 min at RT. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:120 for 12 hours at 4°C. Secondary Antibody: FITC Goat Anti-Rabbit (green) at 1:200 for 2 hours at RT. Counterstain: DAPI (blue) nuclear stain at 1:40000 for 2 hours at RT. Localization: Cytoplasm. Exosome. Magnification: 100x. (A) DAPI (blue) nuclear stain. (B) Anti-BVR Antibody. (C) Composite. Western blot analysis of Human, Rat Brain cell lysates showing detection of BVR protein using Rabbit Anti-BVR Polyclonal Antibody . Lane 1: Rat Brain. Lane 2: Human Brain lysates. Load: 10 µg. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:1000. 100 μg 3 to 4 Days
$505.70
Details
Human Rabbit FITC IP, IHC, WB Immunohistochemistry analysis using Rabbit Anti-BVR Polyclonal Antibody . Tissue: Ischemic brain. Species: Rat. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:1000. C = ischemic core, P = ischemic penumbra. Western blot analysis of Human, Rat Brain cell lysates showing detection of BVR protein using Rabbit Anti-BVR Polyclonal Antibody . Lane 1: Rat Brain. Lane 2: Human Brain lysates. Load: 10 µg. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:1000. 100 μg 3 to 4 Days
$505.70
Details
Human Rabbit APC IP, IHC, WB Immunohistochemistry analysis using Rabbit Anti-BVR Polyclonal Antibody . Tissue: Ischemic brain. Species: Rat. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:1000. C = ischemic core, P = ischemic penumbra. Western blot analysis of Human, Rat Brain cell lysates showing detection of BVR protein using Rabbit Anti-BVR Polyclonal Antibody . Lane 1: Rat Brain. Lane 2: Human Brain lysates. Load: 10 µg. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:1000. 100 μg 3 to 4 Days
$514.80
Details
Human Rabbit PerCP IP, IHC, WB Immunohistochemistry analysis using Rabbit Anti-BVR Polyclonal Antibody . Tissue: Ischemic brain. Species: Rat. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:1000. C = ischemic core, P = ischemic penumbra. Western blot analysis of Human, Rat Brain cell lysates showing detection of BVR protein using Rabbit Anti-BVR Polyclonal Antibody . Lane 1: Rat Brain. Lane 2: Human Brain lysates. Load: 10 µg. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:1000. 100 μg 3 to 4 Days
$514.80
Details
Human Rabbit APC ICC, IF, IP, IHC, WB Immunocytochemistry/Immunofluorescence analysis using Rabbit Anti-BVR Polyclonal Antibody . Tissue: HeLa Cells. Species: Human. Fixation: 2% Formaldehyde for 20 min at RT. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:120 for 12 hours at 4°C. Secondary Antibody: FITC Goat Anti-Rabbit (green) at 1:200 for 2 hours at RT. Counterstain: DAPI (blue) nuclear stain at 1:40000 for 2 hours at RT. Localization: Cytoplasm. Exosome. Magnification: 100x. (A) DAPI (blue) nuclear stain. (B) Anti-BVR Antibody. (C) Composite. Western blot analysis of Human, Rat Brain cell lysates showing detection of BVR protein using Rabbit Anti-BVR Polyclonal Antibody . Lane 1: Rat Brain. Lane 2: Human Brain lysates. Load: 10 µg. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:1000. 100 μg 3 to 4 Days
$514.80
Details
Human Rabbit PerCP ICC, IF, IP, IHC, WB Immunocytochemistry/Immunofluorescence analysis using Rabbit Anti-BVR Polyclonal Antibody . Tissue: HeLa Cells. Species: Human. Fixation: 2% Formaldehyde for 20 min at RT. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:120 for 12 hours at 4°C. Secondary Antibody: FITC Goat Anti-Rabbit (green) at 1:200 for 2 hours at RT. Counterstain: DAPI (blue) nuclear stain at 1:40000 for 2 hours at RT. Localization: Cytoplasm. Exosome. Magnification: 100x. (A) DAPI (blue) nuclear stain. (B) Anti-BVR Antibody. (C) Composite. Western blot analysis of Human, Rat Brain cell lysates showing detection of BVR protein using Rabbit Anti-BVR Polyclonal Antibody . Lane 1: Rat Brain. Lane 2: Human Brain lysates. Load: 10 µg. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:1000. 100 μg 3 to 4 Days
$514.80
Details
Human Rabbit Atto 594 ICC, IF, IP, IHC, WB Immunocytochemistry/Immunofluorescence analysis using Rabbit Anti-BVR Polyclonal Antibody . Tissue: HeLa Cells. Species: Human. Fixation: 2% Formaldehyde for 20 min at RT. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:120 for 12 hours at 4°C. Secondary Antibody: FITC Goat Anti-Rabbit (green) at 1:200 for 2 hours at RT. Counterstain: DAPI (blue) nuclear stain at 1:40000 for 2 hours at RT. Localization: Cytoplasm. Exosome. Magnification: 100x. (A) DAPI (blue) nuclear stain. (B) Anti-BVR Antibody. (C) Composite. Western blot analysis of Human, Rat Brain cell lysates showing detection of BVR protein using Rabbit Anti-BVR Polyclonal Antibody . Lane 1: Rat Brain. Lane 2: Human Brain lysates. Load: 10 µg. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:1000. 100 μg 3 to 4 Days
$516.10
Details
Human Rabbit Atto 594 IP, IHC, WB Immunohistochemistry analysis using Rabbit Anti-BVR Polyclonal Antibody . Tissue: Ischemic brain. Species: Rat. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:1000. C = ischemic core, P = ischemic penumbra. Western blot analysis of Human, Rat Brain cell lysates showing detection of BVR protein using Rabbit Anti-BVR Polyclonal Antibody . Lane 1: Rat Brain. Lane 2: Human Brain lysates. Load: 10 µg. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:1000. 100 μg 3 to 4 Days
$516.10
Details
Human Rabbit Atto 680 ICC, IF, IP, IHC, WB Immunocytochemistry/Immunofluorescence analysis using Rabbit Anti-BVR Polyclonal Antibody . Tissue: HeLa Cells. Species: Human. Fixation: 2% Formaldehyde for 20 min at RT. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:120 for 12 hours at 4°C. Secondary Antibody: FITC Goat Anti-Rabbit (green) at 1:200 for 2 hours at RT. Counterstain: DAPI (blue) nuclear stain at 1:40000 for 2 hours at RT. Localization: Cytoplasm. Exosome. Magnification: 100x. (A) DAPI (blue) nuclear stain. (B) Anti-BVR Antibody. (C) Composite. Western blot analysis of Human, Rat Brain cell lysates showing detection of BVR protein using Rabbit Anti-BVR Polyclonal Antibody . Lane 1: Rat Brain. Lane 2: Human Brain lysates. Load: 10 µg. Primary Antibody: Rabbit Anti-BVR Polyclonal Antibody  at 1:1000. 100 μg 3 to 4 Days
$516.10
Details

Top referenced anti-Biliverdin Reductase Antibodies

  1. Human Polyclonal Biliverdin Reductase Primary Antibody for IHC, IHC (p) - ABIN4284633 : Gromov, Espinoza, Talman, Honma, Kroman, Timmermans Wielenga, Moreira, Gromova: FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast. in PLoS ONE 2014 (PubMed)

More Antibodies against Biliverdin Reductase Interaction Partners

Zebrafish Biliverdin Reductase A (BLVRA) interaction partners

  1. Suggest that Gata-1 and Nrf2a play differential roles in regulating the heme degradation enzymes hmox1a/bvra/bvrb during an early developmental period of heightened cellular stress

Human Biliverdin Reductase A (BLVRA) interaction partners

  1. Data found that BVR-A interacts with BACE1, and its loss would favor the CKI-mediated phosphorylation of BACE1 and the associated increased Abeta production along with the alteration of brain insulin signaling. These results suggest that the impairment of BVR-A is an early molecular event contributing to both the onset of brain insulin resistance and the increased Abeta production observed in Alzheimer disease.

  2. Genetic polymorphisms of the UGT1A1 promoter, specifically the T-3279G phenobarbital-responsive enhancer module and (TA)7 dinucleotide repeat, as well as the intron and coding region variants of the OATP2, HMOX1, and BLVRA genes, were significantly higher among the cases than the controls.

  3. BLVRA mRNA levels in the liver as well as in peripheral blood leukocytes are significantly higher in hepatocellular carcinoma patients most likely as a feedback mechanism to control increased oxidative stress associated with HCC progression.

  4. Data suggest that isoenzymes BVRA and BVRB play different roles in energy metabolism and in pathogenesis of abdominal obesity and hypertriglyceridemia. [REVIEW]

  5. Interactions of HO-2 with CPR and BVR, were evaluated.

  6. Activation of human biliverdin-IXalpha reductase by urea: generation of kinetically distinct forms during the unfolding pathway.

  7. These findings suggest that hBVR significantly contributes to the modulation of hypoxia-induced chemoresistance of glioblastoma cells by adjusting their cellular redox status.

  8. Increased biliverdin reductase expression is associated with multidrug resistance in leukemia.

  9. Our results suggest that patients with chronic HCV infection significantly upregulate BLVRA expression in PBL.

  10. The current study reports increased levels of both HO-1 and BVR-A in plasma from probable Alzheimer disease patients, as a result of the increased oxidative environment.

  11. rs699512 (Thr3Ala), the only common non-synonymous SNP within BLVRA, reduced the risk of essential hypertension in Kazaks.

  12. A significant increase of nitrated BVRA was demonstrated only in Alzheimer's disease and mild cognitive impairment hippocampi

  13. A homozygous BLVRA inactivating mutation is associated with the appearance of green jaundice accompanying cholestasis episodes.

  14. data support the notion that BLVRA contributes significantly to modulation of the aging process by adjusting the cellular oxidative status.

  15. An up-regulation of the biliverdin reductase-A protein levels was found in the hippocampus of the subjects with Alzheimer disease and arguably its earliest form, mild cognitive impairment.

  16. hBVR was detected in the nucleus at 1, 2, and 4 h after hypoxia (1% O(2)), at which times its kinase and reductase activities were increased.

  17. These observations support direct and indirect antioxidant properties of BVR and bilirubin and an important role for BVR and bilirubin in HO-1 conferred protection of endothelial cells.

  18. Primary spontaneous pneumothorax in smokers is associated with lung macrophage oxidative stress. The response to this condition involves HIF-1alpha-mediated induction of HO-1, BVR and H-ferritin.

  19. hBVR is a regulator of the TNF-alpha-GPBP-collagen type IV signaling cascade

  20. Bilirubin, acting as a cytoprotective antioxidant, is itself oxidized to biliverdin and then recycled by biliverdin reductase back to bilirubin. This redox cycle may constitute the principal physiologic function of bilirubin.

Mouse (Murine) Biliverdin Reductase A (BLVRA) interaction partners

  1. macrophages lacking BVR-A are characterized by the expression of M1 polarization-associated chemokines, the levels of which depend in part on C5aR1 signaling.

  2. BVR-A is potential therapeutic target to prevent brain insulin resistance in Alzheimer's disease.

  3. this study shows that absence of the biliverdin reductase-a gene is associated with increased endogenous oxidative stress

  4. These findings reveal a novel BVRA-GSKbeta-PPARalpha axis that regulates hepatic lipid metabolism and may provide unique targets for the treatment of non-alcoholic fatty liver disease.

  5. BVR-A integrates both oxidative/nitrosative stress- and insulin-mediated signaling, both mechanisms dysregulated in the Alzheimer disease brain.

  6. The biliverdin reductase A positive macrophage is a source of anti-inflammatory cytokine IL-10 in injured kidney.

  7. Lack of p53 decreases basal oxidative stress levels in the brain through upregulation of thioredoxin-1, biliverdin reductase-A, manganese superoxide dismutase, and nuclear factor kappa-B.

  8. biliverdin reductase has a role in regulating the inflammatory response to endotoxin that requires eNOS-derived NO and TLR4 signaling in macrophages

  9. Results describe the activation of biliverdin-IXalpha reductase by inorganic phosphate and related anions.

  10. biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt

  11. Inhibition of biliverdin reductase increases ANG II-dependent superoxide levels in cultured renal tubular epithelial cells.

Cow (Bovine) Biliverdin Reductase A (BLVRA) interaction partners

  1. biliverdin reductase A (BLVRA) was identified as a partner of ELSPBP1 by immunoprecipitation followed by tandem mass spectrometry.

Biliverdin Reductase (BLVRA) Antigen Profile

Protein Summary

The protein encoded by this gene belongs to the biliverdin reductase family, members of which catalyze the conversion of biliverdin to bilirubin in the presence of NADPH or NADH. Mutations in this gene are associated with hyperbiliverdinemia. Alternatively spliced transcript variants have been found for this gene.

Gene names and symbols associated with BLVRA

  • biliverdin reductase A (BLVRA) antibody
  • biliverdin reductase A (blvra) antibody
  • biliverdin reductase A L homeolog (blvra.L) antibody
  • CG9471 gene product from transcript CG9471-RA (CG9471) antibody
  • biliverdin reductase A (Blvra) antibody
  • 0610006A11Rik antibody
  • 2500001N03Rik antibody
  • Blvr antibody
  • BLVRA antibody
  • BVR antibody
  • BVRA antibody
  • Dmel\\CG9471 antibody
  • MGC69310 antibody
  • zgc:153046 antibody

Protein level used designations for BLVRA

biliverdin reductase A , CG9471-PA , CG9471-PB , biliverdin IX-beta reductase , biliverdin reductase , biliverdin reductase a , BVR A , biliverdin-IX alpha-reductase

GENE ID SPECIES
420776 Gallus gallus
448743 Xenopus (Silurana) tropicalis
463366 Pan troglodytes
475867 Canis lupus familiaris
700980 Macaca mulatta
767661 Danio rerio
100137674 Xenopus laevis
41197 Drosophila melanogaster
100528810 Ictalurus punctatus
644 Homo sapiens
109778 Mus musculus
116599 Rattus norvegicus
504596 Bos taurus
100515289 Sus scrofa
Selected quality suppliers for anti-Biliverdin Reductase (BLVRA) Antibodies
Did you look for something else?